These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25242236)

  • 1. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
    Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
    Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits.
    Necula LG; Chivu-Economescu M; Stanciulescu EL; Bleotu C; Dima SO; Alexiu I; Dumitru A; Constantinescu G; Popescu I; Diaconu CC
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):23-9. PubMed ID: 22457856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese.
    Huang B; Liu B; Yang L; Li Y; Cheng M; Huang D; Wang H; Zhang X; Zheng J; Li Q; Ji W; Zhou Y; Lu J
    Int J Cancer; 2012 Sep; 131(5):E744-58. PubMed ID: 22189957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of inflammasomes in lung cancer cell lines and tissues.
    Kong H; Wang Y; Zeng X; Wang Z; Wang H; Xie W
    Tumour Biol; 2015 Sep; 36(10):7501-13. PubMed ID: 25910707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
    Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
    Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
    Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
    Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
    Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM8 as a novel serological and histochemical marker for lung cancer.
    Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
    Chen P; Yu J; Knecht J; Chen Q
    Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.
    Huang SF; Liu HP; Li LH; Ku YC; Fu YN; Tsai HY; Chen YT; Lin YF; Chang WC; Kuo HP; Wu YC; Chen YR; Tsai SF
    Clin Cancer Res; 2004 Dec; 10(24):8195-203. PubMed ID: 15623594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
    Mu XL; Li LY; Zhang XT; Wang MZ; Feng RE; Cui QC; Zhou HS; Guo BQ
    Clin Cancer Res; 2005 Jun; 11(12):4289-94. PubMed ID: 15958609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
    Shin KC; Choi EY; Chung JH; Jeon C; Lee KH
    Anticancer Res; 2012 Jan; 32(1):163-7. PubMed ID: 22213302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
    Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
    Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.
    Pilati C; Amessou M; Bihl MP; Balabaud C; Nhieu JT; Paradis V; Nault JC; Izard T; Bioulac-Sage P; Couchy G; Poussin K; Zucman-Rossi J
    J Exp Med; 2011 Jul; 208(7):1359-66. PubMed ID: 21690253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.
    Pilati C; Zucman-Rossi J
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):499-506. PubMed ID: 26188635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.